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Abstract
Background: The extracellular matrix (ECM), one of the key components of tumor microenvironment, has a
tremendous impact on cancer development and highly influences tumor cell features. ECM affects vital
cellular functions such as cell differentiation, migration, survival and proliferation. Gene and protein expression
levels are regulated in cell-ECM interaction dependent manner as well. The rate of unsuccessful clinical trials,
based on cell culture research models lacking the ECM microenvironment, indicates the need for alternative
models and determines the shift to three-dimensional (3D) laminin rich ECM models, better simulating tissue
organization. Recognized advantages of 3D models suggest the development of new anticancer treatment
strategies. This is among the most promising directions of 3D cell cultures application. However, detailed
analysis at the molecular level of 2D/3D cell cultures and tumors in vivo is still needed to elucidate cellular
pathways most promising for the development of targeted therapies. In order to elucidate which biological
pathways are altered during microenvironmental shift we have analyzed whole genome mRNA and miRNA
expression differences in LLC1 cells cultured in 2D or 3D culture conditions.
Methods: In our study we used DNA microarrays for whole genome analysis of mRNA and miRNA expression
differences in LLC1 cells cultivated in 2D or 3D culture conditions. Next, we indicated the most common
enriched functional categories using KEGG pathway enrichment analysis. Finally, we validated the microarray
data by quantitative PCR in LLC1 cells cultured under 2D or 3D conditions or LLC1 tumors implanted in
experimental animals.
Results: Microarray gene expression analysis revealed that 1884 genes and 77 miRNAs were significantly
altered in LLC1 cells after 48 h cell growth under 2D and ECM based 3D cell growth conditions. Pathway
enrichment results indicated metabolic pathway, MAP kinase, cell adhesion and immune response as the most
significantly altered functional categories in LLC1 cells due to the microenvironmental shift from 2D to 3D.
Comparison of the expression levels of selected genes and miRNA between LLC1 cells grown in 3D cell
culture and LLC1 tumors implanted in the mouse model indicated correspondence between both model
systems.
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Conclusions: Global gene and miRNA expression analysis in LLC1 cells under ECM microenvironment
indicated altered immune response, adhesion and MAP kinase pathways. All these processes are related to
tumor development, progression and treatment response, suggesting the most promising directions for the
development of targeted therapies using the 3D cell culture models.
Keywords: 3D cell culture, ECM, Gene and miRNA expression signature, MAPK signaling pathway, Cell
adhesion, Inflammatory response
Background
The extracellular matrix (ECM), as one of the key com-
ponents of tumor microenvironment, has a significant
impact on cancer development and highly influences
tumor cell features and therefore the response to treat-
ment [1]. ECM contributes not only structural support
of growing tumor cells, but also affects other cellular
functions such as cell differentiation, migration, survival
or proliferation [2–4]. Moreover, gene and protein
expression levels are regulated in cell-ECM interaction
dependent manner [5, 6]. Not surprisingly, clinical trials
based on preclinical two-dimensional (2D) monolayer
cell culture models which lack representation of ECM
dependent molecular processes occurring in tumors
currently have a failure rate of up to 95 %. Cancer cell
growth under three-dimensional (3D) culture conditions
simulating ECM microenvironment better resembles
tumor cell properties in vivo [7]. Thus, investigations
using such 3D cell culture models are expected to result
in more successful clinical trials.
Vast amount of evidence indicates the superiority of
3D cell cultures compared to 2D models for investigating
cancer tumor microenvironment dependent cancer cell
properties [8, 9]. Obvious advantages of 3D cell culture
models are the cellular-ECM interactions and cell-cell
contacts, the formation of active proliferation, quies-
cent viable cell and necrotic cell zones, as well as the
formation of nutritional, oxygen and drug gradients
better reflecting cellular organization and the micro-
environment in tumor tissue [10]. Nevertheless, the
3D cell cultures do not resemble the full complexity
of tumor tissue environment in vivo. Few obvious
limitations of 3D cell cultures as a cancer research
model are the lack of vasculature, host immune re-
sponse and other cell-cell interactions that occur between
cancer and stromal cells in tumors [11]. Recognized ad-
vantages and limitations of 3D cell culture models suggest
that the most successful directions of 3D model applica-
tion include the development of new anticancer treatment
strategies. Hence, detailed analysis at the molecular level
of 2D/3D cell cultures and tumors in vivo are still needed
to unlock the power of 3D cell culture models in transla-
tional research.
In order to elucidate which biological pathways are al-
tered during microenvironmental shift, we have analyzed
whole genome mRNA and miRNA expression changes
in murine Lewis lung cancer LLC1 cells cultured in 2D
or laminin rich ECM (lr-ECM) 3D conditions. LLC1 cell
line was established from the lung of a C57BL mouse
bearing a tumor of primary Lewis lung carcinoma. This
cell line is highly tumorigenic and the implanted cells are
immunologically compatible with the murine immune
system, unlike the widely used human cancer xenograft
models. Therefore, it is primarily used as singeneic animal
model as well as evaluating the efficacy of chemotherapeu-
tic agents in vivo. The present pathway enrichment results
indicated the metabolic pathway, MAP kinase, cell adhe-
sion and immune response as the most significantly al-
tered functional categories in LLC1 cells during the switch
from 2D to 3D. Global miRNA expression analysis con-
firmed the involvement of miRNA in the regulation of
ECM dependent properties of cancer cells. Comparison of
the expression levels of selected genes and miRNA be-
tween LLC1 cells grown 3D cell culture and LLC1 tumors
implanted in mice indicated correspondence between
both model systems. Global gene and miRNA expression
analysis indicates the existence of universal regulation for
the metabolic pathway, MAPK, cell adhesion and immune
response pathways both in 3D culture and tumor suggest-
ing the most promising directions for translational cancer
research using the 3D cell culture models.
Methods
Cell culture and maintenance
LLC1 mouse Lewis lung carcinoma cell line was
obtained from the ATCC (Rockville, Maryland, USA).
Cells were cultured under standard conditions at 37 °C
in a humidified atmosphere containing 5 % CO2 with
DMEM medium (ThermoFisher Scientific, USA) supple-
mented with 10 % fetal bovine serum (ThermoFisher
Scientific, USA), 2 mM glutamine (ThermoFisher Scientific,
USA), 100 UI/ml penicillin (Sigma, USA) and 0.1 mg/ml
streptomycin (Sigma, USA). For 2D culture, cells were
plated in 6 well plates at 5x104 cells/cm2 density. For lr-
ECM 3D cell culture, 24 well plates were coated with 1 %
agarose to prevent the attachment of cells to the plate
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bottom and 5x104 cells per well were embedded into
0.5 mg/ml lr-ECM protein mixture Geltrex (Thermo-
Fisher Scientific, USA) in DMEM medium as described
previously [12]. All experiments were performed following
48 h of cell growth and repeated at least 3 times. Repre-
sentative phase contrast images of live LLC1 cells grown
under 2D and lr-ECM 3D cell culture conditions were
taken using Nikon T5100 microscope.
Tumor model
C57BL/6 female mice (obtained from Vilnius University
Institute of Biochemistry) at 10–12 weeks of age and 19–
22 g body weight were used. Mice were injected subcuta-
neously with Lewis lung carcinoma (LLC1) cells (1x106
cells suspended in RPMI medium) in the right groin. Ani-
mals were sacrificed, tumors excised, homogenized and
resuspended in normal saline 10 days following the im-
plantation. Experimental group of mice were injected with
0.2 ml of the obtained suspension in the right groin. Mice
were housed at a constantly maintained temperature (22
± 1 °C), relative humidity (55 ± 10 %) and photoperiod
(12 h light/dark cycle) in the Open Access Centre at Na-
tional Cancer Institute, Lithuania. The animals were fed
standard rodent chow and purified water ad libitum.
Tumor volume was determined by measuring the diam-
eter with vernier calipers and calculating the volume
according to the following formula: tumor volume = L x
W x H x π/6 (L is length, W is width and H is height of
tumor). Tumors reached 400–600 mm3 volume in 10 days
following implantation. Then animals were sacrificed and
tumors excised and used for total RNA isolation. All ani-
mal procedures were performed in accordance with the
guidelines established by the Lithuanian Care Committee
which approved the study (No.0190)
Confocal imaging
5x104 LLC1 cells were plated in 24 well plates on glass
cover slips in DMEM or embedded into 0.5 mg/ml lr-
ECM/DMEM mixture under 2D or 3D cell culture condi-
tions, respectively. Following 48 h of growth, cells were
washed twice with PBS and fixed for 10 min. with 4 %
PFA (Carl ROTH, Germany) solution in PBS at room
temperature. Cell permeabilization was performed with
ice-cold 0,1 % Triton X-100 in PBS for 10 min. Staining
was accomplished with Alexa®633 Phalloidin (Thermo-
Fisher Scientific, USA) in PBS containing 1 % BSA for
30 min and 5 μg/ml Dapi (Sigma, USA) in PBS for 3 min
at room temperature. All staining steps were followed by
3 wash steps in PBS for 5 min at room temperature. Fi-
nally, slides were mounted with Roti®-MountFluorCare
mounting media (Carl ROTH, Germany). Images were ob-
tained using Zeiss LSM 7 Duo Live confocal microscope
(Zeiss, Germany) and 40x/1.3 immersion objective and ex-
citation wavelengths of 405 nm and 633 nm.
RNA and miRNA extraction
1x106 LLC1 cells following 48 h of growth under 2D or
lr-ECM 3D cell culture conditions were harvested and
total RNA enriched with small noncoding RNAs was
isolated using mirVana RNA isolation kit (Ambion,
USA) according to manufacturer’s instructions. 100 mg
of mouse tumor tissue sample were used for total RNA
extraction. The quantity and quality of RNA were mea-
sured using Nanodrop (ThermoFisher Scientific, USA)
and Bioanalyzer (Agilent Technologies, USA).
Gene expression microarrays
cRNA sample preparation, labeling and hybridization
was performed according to manufacturer’s instruc-
tions. Briefly, 1 μg of total RNA was used for cDNA
synthesis and amplification using Message™Amp aRNA
kit (ThermoFisher Scientific, USA). Then 825 ng of cRNA
labeled with Cy3/Cy5 dyes using Arcturus® TURBO label-
ing™ Cy™3/Cy™5 Kit (ThermoFisher Scientific, USA) were
hybridized to Agilent Mouse Whole Genome 4x44k
Oligonucleotide Microarrays (Agilent Technologies, USA)
using HS 400 hybridization station (Tecan, Switzerland).
Three independent replicates of every sample were used.
Microarray slides were scanned using LS Reloaded scan-
ner (Tecan, Switzerland). Microarray image analysis and
data generated were further analyzed using ImaGene ver.
9.0 (BioDiscovery, USA) and GeneSpring GX v11.5
software (Agilent Technologies, USA). Raw extracted gene
expression data were normalized with Loess
normalization to adjust microarray data for variation.
Genes that showed expression values above fold change
1.5 (with p-value <0.05) were defined as differentially
expressed in LLC1 cells between 2D and 3D cell culture
conditions. Microarray design and data are available at the
GEO database (Accession No. GSE75863 http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE75863).
MiRNA expression microarrays
miRNA labeling was performed using miRNA complete
labeling and Hyb kit (Agilent technologies, USA) accord-
ing to manufacturer’s instructions. In brief, 100 ng of
total RNA were dephosphorylated and directly labeled
with Cy3. Samples were dried out and resuspended in
Hi-RPM hybridization buffer (Agilent Technologies,
USA), containing GE blocking agent (Agilent Technolo-
gies, USA) and denaturized by heating for 5 min in 100 °C.
In a further step samples were hybridized to Agilent mouse
miRNA 8x15K microarrays containing probes for 627
mouse miRNAS from Sanger database v.12 (Agilent
Technologies, USA) for 20 h at 55 °C in a rotating
hybridization oven. Three independent replicates of every
sample were used. Slides were then washed 3 times and
scanned with Agilent SureScan Microarray Scanner
(Agilent Technologies, USA). Microarray images were
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extracted using Extraction Feature v10.7.3.1 software
(Agilent Technologies, USA). To normalize raw probe
values, experimental samples were scaled to mean of
control samples using GeneSpring GX v11.5 software
(Agilent Technologies, USA). miRNAs that showed ex-
pression values above fold change 2 (with P-value <0.05)
were defined as differentially expressed in LLC1 cells
between 2D and 3D cell culture conditions. Micro-
array data are available at the GEO database (Accession
No. GSE75862, http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE75862).
Microarray data enrichment analysis
To classify microarray data we selected KEGG pathway
enrichment analysis which provided the most extensive
pathway enrichment results compared to other open ac-
cess toolkits. KEGG pathway enrichment analysis of
gene expression data was performed using WebGestalt
online source, as described previously [13]. P values were
calculated using hypergeometric test and adjusted with
multiple Benjamini and Hochberg testing. Functional
categories associated in at least 5 genes and P < 0.05 were
defined as significant. miRNA target and KEGG pathway
enrichment analysis was performed with Diana Tools
using microT-CDS algorithm and MirPath, as described
previously [14, 15].
Quantitative RT-PCR
To validate gene expression changes, 1 μg of total RNA
was used for cDNA synthesis with RevertAid RT Kit
(ThermoFisher Scientific, USA) according to manufac-
turer’s instructions. To evaluate miRNA expression, 0.2 μg
of total RNA was used to perform cDNA synthesis with
RevertAid RT Kit (ThermoFisher Scientific, USA) as de-
scribed previously [16]. Quantitative real-time PCR (qRT-
PCR) was performed on Eco™ RT-PCR system (Illumina,
Inc.) using 2x Maxima SYBR Green qPCR MasterMix
(ThermoFisher Scientific, USA) according to manufac-
turer’s instructions. The relative changes in gene and
miRNA expression were calculated by ΔΔCt method com-
paring expression levels in LLC1 cells grown under 2D
and lr-ECM 3D or LLC1 tumors with hprt1 or sno135 as
endogenous controls for expression normalization, re-
spectively. The primer sequences used for microarray data
validation are shown in Additional file 1: Table S1.
Statistical analysis
Data were analyzed using GraphPad v6.0 software.
Student’s t test was used to compare differences between
two groups. P < 0.05 was considered as statistically
significant. All experiments were independently repeated
at least 3 times.
Results
Cell morphology
To elucidate structural changes in cellular morphology
we examined mouse Lewis lung carcinoma LLC1 cells
grown under 2D or lr-ECM 3D cell culture conditions.
Cells lost their flat elongated morphology and gained
3-dimensional characteristic mass view following 48 h of
cell growth in 3D conditions (Fig. 1a). Further, in order to
visualize cell actin cytoskeleton changes, we also per-
formed confocal microscopy of cells stained with phal-
loidin (Fig. 1b). Images showed that cells had undergone a
significant actin cytoskeleton rearrangement and actin
stress fibers were lost under 3D culture conditions.
Gene expression pattern in LLC1 cells grown under
lr-ECM 3D conditions
To better understand the impact of cellular micro-
environment changes on gene expression levels in
LLC1 cells grown under 2D and lr-ECM 3D condi-
tions, we analyzed genome wide expression changes
between these culture conditions using Agilent Mouse
Whole Genome 4x44k Oligonucleotide Microarray
platform. Microarray data revealed that the expression
of 1884 genes was significantly altered (>1.5 fold
change, p < 0.05) following 48 h cell growth under 2D and
lr-ECM 3D conditions (Additional file 2: Table S2). Differ-
ences in cell culture conditions resulted in a greater
number of down-regulated than up-regulated genes (1052
and 832, respectively; Table 1). In order to evaluate which
biological pathways were affected in LLC1 cells between
2D and 3D cell growth conditions, we performed KEGG
pathway enrichment analysis of all 1884 differently
expressed genes. KEGG pathway enrichment analysis re-
vealed that total of 74 KEGG pathway categories were
enriched where each of these categories was represented
at least by five or more genes in the functional category
with p < 0.05 (Additional file 3: Table S3). A greater num-
ber of genes in all categories were down-regulated in
LLC1 cells under 3D culture conditions as compared to
2D. Next, we coalesced similar KEGG pathway categories
into four subsets of major functional groups, which could
be related to tumor development and progression: 1)
Metabolic pathways; 2) MAP kinase; 3) Cell adhesion
and 4) Immune response related pathways (Table 2).
Our results indicated that the “Metabolic pathways”
subset was the most significantly altered KEGG functional
category (p = 6.23e-08) resulting in 73 (30 up-regulated
and 43 down-regulated) differently expressed genes in
LLC1 cells grown under lr-ECM 3D vs monolayer condi-
tions. The MAP kinase signaling pathway was the second
most significantly altered KEGG categories (p = 6.23e-08)
and resulted in 25 genes (11 up-regulated and 14 down-
regulated) differently expressed in LLC1 cells cultured
under lr-ECM 3D and 2D culture conditions. Differences
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in cell culture conditions also altered the expression of 48
unique (22 up-regulated and 26 down-regulated) genes
related to cell adhesion. These genes were significantly
associated with cell adhesion molecules, gap and tight
junctions, ECM-receptor interaction functional categories,
with “regulation of actin cytoskeleton” (p = 1.35e-06) and
“focal adhesion” (p = 3.33e-05) categories being the most
significantly altered in the “cell adhesion” subset. Further-
more, we indicated that difference in cell culture condi-
tions also altered the expression of 44 (16 up-regulated
and 28 down-regulated) genes involved in immune
response signaling pathways including cytokine-cytokine
receptor, chemokine, T and B cell receptor and Jak-STAT
signaling pathway categories (Table 2). Differently
expressed genes associated to MAP kinase, cell adhesion
and immune response pathway categories are listed in
Additional file 4: Table S4.
miRNA expression pattern in LLC1 cells grown under
lr-ECM 3D conditions
For miRNA expression profile analysis, we evaluated
miRNA expression changes under two different cell cul-
ture conditions using Mouse miRNA 8x15k Microarrays.
Following 48 h of cell growth the expression of 77 miR-
NAs was significantly altered (>2 fold change, p < 0.05)
and resulted in 41 up-regulated and 36 down-regulated
miRNAs in LLC1 cells cultivated under lr-ECM 3D
culture conditions compared to miRNA expression levels
in cells cultured on plastic (Table 1, Additional file 5:
Table S5). Next, to obtain a better overview of miRNA
expression signature, we further performed unsupervised
hierarchical clustering heat map analysis of all differen-
tially expressed miRNA by normalized probe signal values
(Fig. 2a). Heat map analysis revealed: a) the expression of
27 miRNAs was strongly induced under lr-ECM 3D cul-
ture conditions and only 3 of these miRNAs, miR-466c,
miR-574 and miR-669n showed high expression values
under 2D cell culture conditions; b) expression of most
miRNAs that were down-regulated under lr-ECM 3D cul-
ture conditions showed moderate to low expression values
in cells grown in 2D monolayer, except expression of miR-
135a and miR-196a. We next checked which members of
miRNA cluster were co-expressed. We found that 16 up-
Table 1 Number of differentially expressed genes and miRNAsa in
LLC1 cells after 48 h growth under 2D and lr-ECM 3D conditions
All Up-regulated Down-regulated
Genes 1884 832 1052
miRNAs 77 41 36
aGene and miRNA expression values are above 1.5 and 2 fold change,
respectively, p < 0.05
Fig. 1 Cell morphology differences of LLC1 cells grown under 2D or lr-ECM 3D growth conditions. Prior to imaging cells were grown under 2D
(upper panel) and lr-ECM 3D (lower panel) cell culture conditions for 48 h. Representative phase contrast (a) and confocal laser scanning microscopy
images (b) of cells under 2D and 3D growing conditions. F-actin was stained with AlexaFluor 633 Phaloidin (red). Nuclei were counterstained with DAPI
(blue). Bars 100 μm (upper panel) and 30 μm (lower panel)
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regulated miRNAs were associated to 3 clusters, located
in chromosome 2 (miR-466 ~ 467 ~ 669 cluster), 9
(miR-34cluster) and 12 (miR-376 cluster) (Fig. 2b)
while members (10 miRNAs) of 3 miRNA clusters located
in chromosomes 2, 12 and X were down-regulated
(Fig. 2c). Interestingly, about 30 % of down-regulated miR-
NAs were located in chromosome X.
RNA-miRNA regulatory network analysis
To better understand the biological processes which
could be regulated by 77 miRNAs deregulated in LLC1
cells between 2D and 3D cell culture conditions, we
indentified 8629 unique target genes potentially regu-
lated by these miRNA using in silico miRNA target
analysis (Additional file 6: Table S6). Next, miRNA path-
way enrichment analysis indicated 69 KEGG categories
significantly enriched in targeted genes revealing that
pathways related to MAPK, cell adhesion and immune
response were also among the most significantly altered
functional categories (Additional file 7: Table S7).
Furthermore, hierarchical clustering analysis of differ-
ently expressed miRNA-associated KEGG pathways also
revealed that some miRNAs displayed a similar pathway
regulation pattern (Additional file 8). For example, most
up-regulated miRNAs of mir-466 ~ 467 ~ 669 cluster
were functionally associated and miR-467b/miR-467d/
miR-467e, miR-297a/miR-466d showed almost identical
patterns. However, hierarchical clustering analysis didn’t
indicate any clear correlations of pathway patterns of
down-regulated miRNAs (Additional file 8).
Finally, we investigated correlations between differently
expressed genes and miRNAs related to Metabolic path-
ways, MAP kinase, Cell adhesion and Immune response
subsets which were the most significantly altered in ECM
dependent manner to indicate any potential miRNA-
mRNA connections in these processes (Table 3). Our re-
sults identified a negative correlation between differential
expression of 17 miRNAs and 16 mRNAs from the meta-
bolic pathway category. In the MAP kinase pathway a
negative correlation was observed between differential
Table 2 KEGG pathway enrichment analysis of genes differently expressed in LLC1 cells between 2D and lr-ECM 3D cell
culture conditions
Category groups All Up-regulated Down-regulated
Genes p value Genes p value Genes p value
Metabolic pathways
Metabolic pathways 73 2.83e–13 30 7.55e–06 43 2.02e–08
MAP Kinase
MAPK signaling pathway 25 6.23e–08 11 0.0010 14 0.0002
Cell adhesion
Regulation of actin cytoskeleton 20 1.35e–06 6 0.0404 14 3.76e–05
Focal adhesion 17 3.33e–05 7 0.0148 10 0.0018
Cell adhesion molecules (CAMs) 10 0.0062 5 0.0368 5 NS
Gap junction 7 0.0103 2 NS 5 0.0174
Tight junction 9 0.0103 5 NS 4 NS
ECM-receptor interaction 6 0.0237 4 0.0257 2 NS
Immune response
Cytokine-cytokine receptor interaction 18 0.0001 6 NS 12 0.0011
T cell receptor signaling pathway 11 0.0003 3 NS 8 0.0011
VEGF signaling pathway 9 0.0004 5 0.0062 4 NS
Cytosolic DNA–sensing pathway 7 0.0013 4 0.0111 3 NS
B cell receptor signaling pathway 7 0.0058 3 NS 4 NS
RIG-I-like receptor signaling pathway 6 0.0121 5 0.0045 1 NS
Natural killer cell mediated cytotoxicity 8 0.0153 3 NS 5 0.0435
Jak–STAT signaling pathway 9 0.0159 3 NS 6 0.0336
Fc epsilon RI signaling pathway 6 0.0186 2 NS 4 NS
Chemokine signaling pathway 9 0.0362 3 NS 6 NS
Toll-like receptor signaling pathway 5 0.0401 4 NS 2 NS
Functional groups of all genes, differentially expressed in LLC cells grown under 3D cell culture conditions, were assign as significant when enriched in at least 5
genes, p < 0.05
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expression of 11 miRNAs and 7 mRNAs. In addition, 14
mRNA targets associated with cell adhesion pathways
reversely correlated with 18 miRNAs. Target analysis also
revealed that 6 differentially expressed genes from the
immune response category reversely correlated with 13
miRNAs.
Microarray gene expression data validation
To validate differential expression of genes and miRNAs
identified by microarrays, we selected 4 up-regulated
genes and miRNAs for qRT-PCR analysis (Fig. 3a and b;
black columns). The expression of selected hnf4a
(Hepatocyte nuclear factor 4a), ifb1 (Interferon beta-1),
Fig. 2 miRNAs regulated in LLC1 cells grown under 2D and lr-ECM 3D cell culture conditions. a) Hierarchical clustering depicting differently
expressed miRNas (>2 fold change, p < 0.05) in LLC1 cells grown under 2D and 3D cell culture conditions. b) List of up-regulated miRNA clusters
and c) down-regulated miRNA clusters in LLC cells grown under lr-ECM 3D cell culture conditions as compared to 2D
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Table 3 Target genes and miRNAs from Metabolic pathways, MAP kinase, Cell Adhesion and Immune Response category groups
showing inverse correlation in LLC1 cells after 48 h growth between 2D and lr-ECM 3D cell culture conditions
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Stankevicius et al. BMC Cancer  (2016) 16:789 Page 8 of 13
klf8 (Kruppel-like factor 8) and fgfr4 (Fibroblast growth
factor receptor 4) genes was significantly up-regulated in
LLC1 cells grown under lr-ECM 3D culture conditions
compared to expression levels in cells cultured on plastic.
All selected miRNAs, miR-207, miR-376c, miR-466f and
miR-195a, also showed significant up-regulation by qPCR.
Hence, qRT-PCR data confirmed gene and miRNA micro-
array data.
Additionally, we also compared the expression of
selected genes and miRNAs between 2D monolayer and
LLC1 tumors (Fig. 3a and b; grey columns). qRT-PCR
analysis clearly showed that all selected genes and miR-
NAs likewise observed in 3D cell culture conditions
were also significantly up-regulated in vivo.
Discussion
The present study revealed that distinct cellular morph-
ology correlated with an altered gene and miRNA ex-
pression profile in mouse Lewis lung carcinoma LLC1
cells grown under lr-ECM 3D cell culture conditions as
compared to 2D monolayer. Our results indicated that
the ECM strongly affected the expression of particular
genes associated with common biological pathways
involved in cancer cell adaptation to 3D cell culture
microenvironment and correlated with deregulated
expression of miRNAs under these conditions. Further-
more, the present study also demonstrated that ECM-
enriched cellular microenvironment induced a shift in
gene and miRNA expression representative to expres-
sion levels in vivo. Hence, these results support the
application of 3D cell culture to obtain more relevant
results for the study of specific miRNAs involved in
cell–ECM interaction and of ECM-mediated signaling
networks in cancer.
Our findings demonstrated markedly altered gene
expression signature of LLC1 cells grown under 2D and
lr-ECM 3D cell culture conditions, as it was observed
previously in other cell lines [17, 18]. In the present
study differences in cell culture conditions resulted in
1884 differently expressed genes demonstrating the
broad influence of ECM environment in gene expression
regulation. In addition, we also found that the expression
of selected hnf4a, infb1, klf8 and fgfr4 genes was signifi-
cantly increased in LLC1 tumors likewise in LLC1 cells
cultured under 3D cell culture conditions compared to
gene expression levels in cells grown on plastic. Further-
more, we observed that metabolic, MAP kinase, cell
adhesion and immune response functional pathway cat-
egories were most significantly altered in LLC1 cells
between 2D and 3D culture conditions. The microarray
data analysis identified differential expression of 73
genes related to metabolic pathways in LLC1 cells grown
under lr-ECM 2D and 3D conditions. We found that the
expression of genes involved in pyrimidine/purine,
glycerophospholipid, unsaturated fatty acid, amino acid,
monosaccharide and drug metabolism were markedly
altered in an ECM dependent manner. This indicates
that culturing LLC1 cells in 3D cell culture rearranges
metabolic functions. In addition, changes in cellular
metabolism are tightly connected to pH, nutrient and
oxygen gradients leading to the formation of prolifera-
tion and hypoxia zones within the tumor microenviron-
ment and 3D cell culture as well [19, 20]. However,
genome-wide analyses of metabolic pathway rearrange-
ment in cancer cells grown in an ECM 3D cell culture
are limited. Our findings are supported by a previous
report that indicated differential expression of genes
involved in xenobiotic and lipid metabolism in HepG2
hepatoma cell spheroids suggesting that cells in a 3D
culture could be more metabolically active compared to
cells grown in monolayer [21]. In addition, Srisomsap et
al. [22] revealed signatures of differentially expressed
Fig. 3 Validation of Microarray gene and miRNA expression data by qPCR. qPCR was performed as described in Methods. qPCR data analysis was
based on 2-ΔΔCt method and gpdh or sno135 were used as housekeeping genes for gene or miRNA qPCR data normalization, respectively. Graph
showing fold changes of a) genes (hnf4a, infb1, klf8 and fgfr4) or b) miRNAs (miR-207, miR-376c-3p, miR-466f-3p and miR-195a-5p) in
LLC1 cells grown under lr-ECM 3D cell culture conditions or in mouse LLC1 tumors compared to expression levels in cells cultivated in
2D. Results show mean ± SD (n = 3)
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proteins associated with anaerobic glycolysis, mitochon-
drial and nucleotide metabolism in HepG2 cells grown
in a collagen based 3D cell culture. Therefore, altogether
these findings suggest that lr-ECM 3D cell culture
significantly rearranges metabolic functions in LLC1
cells. Our findings are also in agreement with a previous
report also indicating that cellular adaptation to a 3D
culture environment significantly alters the expression of
genes involved in ECM and cell adhesion [5, 23]. In
addition, Luca et al. also observed significantly altered
expression of genes involved in MAP kinase pathway
[6]. Strikingly, the study also demonstrated altered EGFR
protein levels and a switch between RAS-MAPK path-
way activation between 2D and lr-ECM 3D environ-
ments implying that cellular behavior in different
microenvironment could promote important mecha-
nisms to acquire resistance during anticancer therapy.
Hence, these findings suggest that the ECM strongly in-
fluences the expression of particular genes associated
with common biological processes that are involved in
cellular adaptation to 3D cell culture conditions. There-
fore, results obtained in cells grown under 3D cell
culture conditions might also be exploited for the devel-
opment of targeted cancer therapy.
Furthermore, in our present data we also observed a
strong modulation of inflammatory genes in LLC1 cells
between 2D and 3D culture conditions. Our findings
indicated an altered expression of 44 immune response
related genes suggesting that ECM plays an important
role in modulating tumor-immune system interactions.
Surprisingly, interferon 1 beta (infb1) was the most
significantly up-regulated inflammatory gene in LLC1
cells under 3D conditions. Interferons have been shown
to promote anti-proliferative, anti-angiogenic and immu-
noregulatory effects on many tumor types [24, 25].
Nevertheless, we also observed increased ifnb1 levels in
mouse LLC1 tumors suggesting that the primary primal
role of elevated basal ifnb1 levels could be more associ-
ated with regulation of tumor immuno-surveillance, but
not necessarily with tumor suppression. Our results also
indicated increased expression of NFAT family nfatc2
and nfatc4 genes in LLC1 cells grown under lr-ECM 3D
culture conditions as compared to 2D. As NFAT tran-
scription factor family was originally identified to medi-
ate the response of immune cells, recent studies have
demonstrated that NFATs also perform important roles
in formation of tumor microenvironment. Activation of
NFAT signaling in cancer cells results in inflammatory
chemokine production eventually leading to recruitment
of inflammatory cells to the tumor [26]. Interestingly, re-
cent report suggested that NFAT2 constitutive activation
in transgenic mice also linked the microenvironment
and the neighboring cells, as both tumor cells expressing
NFAT2 and neighboring wild-type cells up-regulated c-
Myc and STAT3 in spontaneous skin and ovary tumors
[27]. On the other hand, previous reports also associated
NFAT signaling axis to VEGF driven tumor angiogenesis
regulation indicating complex nature of NFAT in
metastatic niche formation [28]. In addition, our results
also depicted the differential expression of cytokine
receptors (il2ra, il12rb2, il21r and il22ra), chemokine
receptors (ccr3, xrc1 and cxcr7) and tumor necrosis
factor receptors (tnfrsf1b, 9, 11a and 25) supporting
further modulation of cross-talk between cancer and
their microenvironment in ECM dependent manner,
which cannot be established in 2D cultures. These
observations suggest that the investigation of the role of
inflammatory genes under 3D cell culture conditions
could be very important to understanding the basal in-
fluence of genes involved in tumor microenvironment –
immune system interactions in vivo. Results obtained
culturing cells under 3D cell conditions could be also
strongly considered in preclinical targeted therapy re-
search, since ECM environment could strongly influence
the responsiveness of tumor cells to immunotherapy.
While it has been well observed that miRNAs regulate
the expression of ECM molecules, emerging evidence
shows that miRNA expression and function could be
significantly affected by the ECM [29, 30]. Consistent
with these observations, in the present study microarray
data demonstrated a signature of significantly altered
expression of 77 miRNAs in LLC1 cells grown under 2D
and lr-ECM 3D cell culture conditions compared to cells
cultured on plastic. Interestingly, our results showed that
ECM strongly induced the up-regulation of miRNA in
LLC1 cells grown under 3D culture conditions. This is
in accordance with a previous report which suggested
that global upregulation of miRNA expression may be
linked with the changes in cellular density [31]. Further-
more, our results also indicated that the ECM induced
upregulation of miR-466 ~ 467 ~ 669 (e.g. miR-466b,c,d),
miR-376 (miR-376a, miR-376b, miR-376c), and miR-34
(miR-34b and miR-34c) clusters. The miR-466 ~ 467 ~
669 cluster is known as one of the largest miRNA
clusters in mouse genome containing 71 miRNAs. A
previous report [32] suggested that members of this
cluster are abundantly expressed during mouse embryo
development and might regulate growth and survival of
embryonic stem cells. On the other hand, it has been
shown that miR-376 cluster miRNAs are associated with
tumorigenesis. For example, elevated expression of miR-
376a promoted tumor cell migration and invasion and
also positively correlated with advanced tumor metasta-
sis and shorter patient survival [33, 34]. In addition,
overexpression of miR-376c increased ovarian cancer
cell survival and was associated with poor response to
chemotherapy [35]. Moreover, elevated levels of miR-
376c were shown in plasma of early stage breast cancer
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patients [36]. By contrast, miR-34 cluster encodes miR-
NAs possessing tumor suppressive properties mediating
apoptosis, cell cycle arrest and senescence [37]. Our
miRNA microarray data were consistent with previous
reports indicating that human cancer cells cultured on
ECM 3D cell culture conditions have also exhibited a
significantly altered miRNA expression profile compared
to cells cultured on plastic [38–40]. ECM 3D cell culture
associated miRNA profiles demonstrated altered expres-
sion of tumor suppressive and oncogenic miRNAs and
also correlated with distinct cellular morphogenesis
under 3D culture conditions highlighting the regulation
of miRNA expression in the ECM dependent manner.
Additionally, we also showed that the expression of se-
lected miR-195a, miR-207, miR-376c and miR-466f miR-
NAs was also significantly increased in mouse LLC1
tumors as compared to miRNA expression levels in 2D
indicating the potential role of these miRNAs in tumor
progression in vivo. Altogether, these findings suggest
that the 3D cell culture should be considered as a critical
experimental approach for essential understanding of
the miRNA biology associated with tumor microenvir-
onment. Indeed, the gene expression signature of 3D
culture of breast cancer cells has been found to define
prognostic value for patients with breast cancer [41].
Understanding how ECM regulates miRNA expression
will also further elucidate how miRNAs determine
tumor development and reveal potential prognostic and
therapeutic opportunities.
Further on we also investigated potential relations be-
tween 77 differently expressed miRNAs and their target
genes to depict possible miRNA-mRNA interactions in
LLC1 cells regulated by ECM microenvironment under
3D cell culture conditions. We found that 8629 unique
target genes could be regulated by these differently
expressed miRNAs. Pathway enrichment analysis also re-
vealed that 69 KEGG pathways were enriched in target
genes related to these miRNAs including pathways in-
volved in tumor development. However, as it is known
that miRNA targets multiple mRNAs, the ability to find
the key pathways by computational approaches is highly
dependent on size of miRNA profile. In addition, the
statistical target analysis approach could be successful if
the miRNA of interest has an effect on the abundance of
expressed target gene, but not if expression of target
gene is regulated only by translational inhibition. Hence,
we focused on negative correlation analysis between
differently expressed miRNA and genes associated with
metabolic, MAPK, cell adhesion and immune response
pathways in LLC1 cells grown under 2D and 3D cell
culture conditions. Indeed, we found that differently
expressed genes associated to these pathways could be
potentially regulated by miRNAs differently expressed in
LLC1 cells.
In the present study the miRNA target filter analysis
identified miRNAs showing inverse correlations with
metabolic genes indicating the role of miRNA in meta-
bolic pathway regulation. For instance, the down-
regulation of miR-9, miR-19a, miR-135a, miR-495 and
miR-590 negatively correlated with the up-regulation of
genes involved in polysaccharide synthesis including
alpha-mannosidase man2a1, glycosyltransferase ext1 and
beta-1,3-galactosyltransferase B3galt6. We also found
that the down-regulation of genes involved lipid metab-
olism including pla2g2c, dhrs9, ppt1 and sc5d inversely
correlated with the up-regulation of miR-297a, miR-346,
miR-466b, miR-466d, miR-468 and miR-669b. In
addition, our results also revealed that the differential
expression of diacylglycerol kinase dgkb and inositol
polyphosphate 5-phosphatase ocrl regulating lipid signal-
ing and membrane trafficking inversely correlated with
the expression of miR-9, miR-126, miR-590 and miR-
466 g, respectively. These findings are supported by
recent studies demonstrating important roles of miRNAs
in metabolic rearrangement occurring in cancer cells
[42, 43]. Furhtermore, our results indicated that the
expression of kras, mknk1 and pak2 kinases involved in
the MAP kinase pathway negatively correlated with the
expression of miR-761, mir-195 and miR-297a, respect-
ively. The target correlation analysis also depicted miR-
34b, miR-34c, miR-466f and miR-500 miRNAs as
potential negative regulators of sos2 gene expression.
However, the evidence implicating miRNAs role in MAP
kinase pathway is still emerging. Previous report sug-
gested that miR-34c may suppress proliferation of lung
cancer cells by inhibition of MAPK pathway [44]. In
addition, previous data also associated regulation of
miRNAs with MAP kinases in pancreatic cancer cells
showing that expression of miR-34a inversely correlated
with MAPK pathway activity [45]. Ichimura et al. also
demonstrated that miR-34a suppressed the expression of
MEK1 leading to repression of the MEK-ERK signalling
axis [46]. In the present study we also observed a signifi-
cant link between deregulated expression of miRNA and
cell adhesion molecules. For example, our results
indicated a negative correlation between expression of
col1a1 and miR-135a, miR-137 and miR-590. In
addition, decreased flna expression might be influenced
by miR-328 and miR-761. These findings are consistent
with a previous report indicating the presence of feed-
back mechanisms that promote ECM molecules, which
are downstream targets of specific miRNA, to regulate
expression of these miRNAs [40]. A similar target en-
richment analysis also revealed that increased expression
of miRNAs might be connected with the regulation of
immune response pathway genes. For example, our re-
sults depicted a negative correlation between expression
of chemokine receptor xcr1 and miR-669b. Additionally,
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we also noted that decreased expression of oas3 might
be affected by numerous miRNAs. Thus, taken together
these findings suggest that metabolic, MAP kinase, cell
adhesion and immune response pathway genes might be
regulated by miRNAs altered in ECM dependent
manner. Therefore, the 3D cell culture model could be
applied not only for further investigation of common
cancer pathways altered in ECM dependent manner but
also for the study of specific miRNAs involved in
ECM-mediated cancer signaling networks. Further
understanding of complex ECM dependent signaling
networks in tumors could direct to novel cancer
treatment strategies.
Conclusions
In conclusion, our study identified significant changes in
gene and miRNA expression that occurred in mouse
Lewis lung carcinoma LLC1 cells during the shift to lr-
ECM 3D cell culture conditions. Our findings suggest
that 3D cell culture should be considered as a critical
experimental approach to uncover the molecular regula-
tion of genes and miRNA involved in tumor cell - tumor
microenvironment interactions in vivo. Furthermore,
results obtained under 3D cell culture conditions could
also be strongly considered in preclinical targeted
therapy development and hold the prognostic and thera-
peutic potential.
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